Posted on 06/29/20
Jerusalem, Israel - June 29, 2020 - New headlines have been made as Tel Aviv-Jerusalem ranked #6 in the world, along with Los Angeles, in startup locations recommended by Global Start Up Genome.
On June 29, 2020, JLM-BioCity hosted a conference "COVID-19 INNOVATION: New York Meets Jerusalem" held a Zoom meeting with the New York-Israel Chamber of Commerce with over 100 in attendance world-wide .
The meeting highlighted exciting innovations taking place in Israel to help fight COVID-19. Four Jerusalem companies pitched their latest developments in the fight against COVID-19, in a session moderated by Noah Berkowitch, SVP, Development Unit Head, Hematology at Bristol-Myers Squibb, and Boris Shor, Director, BioIdea (NY).
The Jerusalem companies presenting were:
~ Omnysense - www.omnysense.com with Ian Solomon, CTO
~ Pepticom - http://www.pepticom.com/ with Immanuel Lerner, CEO
- Respinova - https://www.respinova.com/ with Cliff Ansel, CEO
~ Immunovative Therapies Ltd - www.immunovative.com with Michael Har-Noy, CEO.
Welcoming remarks were led by Michael David, Executive Director, New York-Israel Chamber of Commerce & co-Moderator, who introduced cosponsors: Hamutal Shachar, CEO, JLM-BioCity & co-Moderator; Inon Elroy, Economic Minister to North America, Israel Economic Mission in NYC; and Gerry Stoch, Israel Director, Empire State Development of New York.
Jerusalem Deputy Mayor Fleur Hassan-Hahoum attended this global meeting and previous sessions before they moved online. Meetings had been held at the Azrieli Engineering College where Deborah Shalev is head of Pharmaceutical Engineering. Shalev has been a constant supporter of events organized by JLM-BioCity cofounder Joseph Van Zwaren.
The four diverse companies are promising innovative approaches to coronavirus pandemic treatments.
Concluding the event, invited keynote speaker, Prof Zeev Rotstein, Director General, Hadassah Medical Center gave an overview on his hospital's successful response to the COVID-19 crisis. They have collected plasma from recovered patients to screen and take only glaboglama to use for treating ill or new high risk patients. High viral load is a bad omen for the infected patients according to Rotstein. There are 60 COVID-19 cases now being treated at Hadassah Hospital.
A new feature at this latest Zoom Innovation Meeting was time allotted at the end for breakout rooms. The smaller groups allowed participants to meet and ask questions.
The Israel Economic Mission in New York https://itrade.gov.il/usa/ promotes trade and development between Israel and the United States and held regular missions to Israel before coronavirus limited travel.